Post-recovery COVID-19 and incident heart failure in the National COVID Cohort Collaborative (N3C) study

Husam M Salah1, Marat Fudim2,3, Shawn T O'Neil4

  • 1Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

Nature Communications
|July 15, 2022
PubMed

Insights

Hospitalization for COVID-19 significantly increases the risk of developing new-onset heart failure. This risk is elevated even after recovery, highlighting a critical post-infection concern.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Cardiac complications are recognized in COVID-19.
  • The long-term risk of de novo heart failure post-COVID-19 remains understudied in large populations.

Purpose of the Study:

  • To investigate the association between COVID-19 hospitalization and the subsequent development of new-onset heart failure.
  • To analyze risk factors and demographic variations in heart failure incidence after COVID-19.

Main Methods:

  • Retrospective cohort study using the National COVID Cohort Collaborative (N3C) data.
  • Analysis of 587,330 hospitalized patients (257,075 with COVID-19, 330,255 without).
  • Median follow-up of 367 days, with adjusted hazard ratios calculated.

Main Results:

  • COVID-19 hospitalization was linked to a 45% increased hazard of incident heart failure (HR=1.45).
  • Increased risk was more pronounced in younger patients, White patients, and those with pre-existing cardiovascular disease.
  • 10,979 new heart failure events were recorded during the follow-up period.

Conclusions:

  • Hospitalization for COVID-19 is an independent risk factor for developing incident heart failure.
  • Specific patient subgroups may face a disproportionately higher risk.
  • Findings underscore the importance of cardiac monitoring post-COVID-19 hospitalization.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
41
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
46
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
27
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23